Studies on hemostasis in COVID-19 deserve careful reporting of the laboratory methods, their significance and their limitations

Michael Hardy, Jonathan Douxfils, Marion Bareille, Sarah Lessire, Isabelle Gouin-Thibault, Pierre Fontana, Thomas Lecompte, François Mullier

Résultats de recherche: Contribution à un journal/une revueLettreRevue par des pairs

16 Téléchargements (Pure)

Résumé

We read with much interest the recent observational study of Nougier et al., which aimed at studying thrombin generation (TG) and fibrinolysis profiles of COVID-19 patients admitted to an intensive care unit (ICU) or to an internal medicine ward and receiving various schemes of prophylactic heparin.[1] They reported that thrombin potential remained within normal range despite heparin and that fibrinolysis was decreased in relation with increased plasminogen activator inhibitor 1 (PAI-1) and thrombin-activatable fibrinolysis inhibitor (TAFI) antigen plasma levels. Using the rotational thromboelastometry (ROTEM) delta device with EXTEM reagents and the addition of 0.625µg/mL tPA (referred to as 'TEM-tPA'), they reported decreased clot lysis in COVID-19 patients, which was more pronounced in patients who presented a thrombotic event, compared to event-free patients.

langue originaleAnglais
Pages (de - à)3121-3124
Nombre de pages4
journalJournal of thrombosis and haemostasis : JTH
Volume18
Numéro de publication11
Date de mise en ligne précoce2020
Les DOIs
Etat de la publicationPublié - 1 nov. 2020

Empreinte digitale

Examiner les sujets de recherche de « Studies on hemostasis in COVID-19 deserve careful reporting of the laboratory methods, their significance and their limitations ». Ensemble, ils forment une empreinte digitale unique.

Contient cette citation